Products for Research Use Only
RegisterLogin

Eptifibatide (acetate)

CAT: 0804-HY-B0686B-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-B0686B-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Eptifibatide acetate is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor, with anti-platelet activity[1].
CAS Number
881997-86-0
UNSPSC
12352209
Hazard Statement
H302, H315, H319, H335
Target
Integrin
Type
Peptides
Related Pathways
Cytoskeleton
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Purity
99.84
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C([C@H](CC1=CNC2=CC=CC=C12)NC([C@H](CC(O)=O)NC(CNC([C@H](CCCCNC(N)=N)N3)=O)=O)=O)N4CCC[C@]4(C(N[C@H](C(N)=O)CSSCCC3=O)=O)[H].CC(O)=O.[x]
Molecular Formula
C35H49N11O9S2.xC2H4O2
Molecular Weight
831.96 (free base)
Precautions
H302, H315, H319, H335
References & Citations
[1]Gilchrist IC, et al. Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide. Clin Pharmacokinet. 2003;42 (8) :703-20.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
Launched

Related Products

CatalogName
HY-B0686-01Eptifibatide
HY-B0686AEptifibatide (monoacetate)
HY-166875SApramycin acetate-d7 (acetate)
HY-134716Methyl acetate-PEG1-methyl acetate
HY-W127616-01β-Sitosterol acetate, 40% (contains Campesterol acetate)
HY-P4091A-01LSD (acetate)
HY-P2483B-01Octaarginine (acetate)
HY-P10959A-01Macupatide (acetate)
HY-P10517A-01Sifuvirtide (acetate)
HY-P0013A-01Antide (acetate)

Alternative Products

CatalogName
T38642-01Eptifibatide acetate
BUP06263-01Eptifibatide acetate (148031-34-9 free base)
PT_40510-01Eptifibatide Human (Eptifibatide Human)
H-6654.0005Eptifibatide

Popular Products